Impact of the COVID-19 pandemic on the treatment of myocardial ischemia in health systems
DOI:
https://doi.org/10.33448/rsd-v11i11.33306Keywords:
COVID-19; Research in Public Health Systems; Myocardial Ischemia.Abstract
Objective: To identify the impact of COVID-19 on the treatment of Myocardial Ischemia in global health systems during the pandemic. Method: Integrative review, carried out in the VHL, CINAHL, MEDLINE and SCOPUS databases, with articles published between November 2019 and April 2021. Results: The sample consisted of 12 original articles, from China, Japan, England, Turkey, Spain, Ireland, United States and France. The number of admissions for cardiovascular events, including ST-segment elevation Myocardial Infarction (STEMI), was reduced. In addition, there was an increase in the time to revascularization and a decrease in the performance of percutaneous coronary intervention (PCI). COVID-19 was associated with worse outcomes in patients with STEMI, such as longer hospital stays, longer intensive care unit stays, and higher mortality. Conclusion: The worldwide treatment of Myocardial Ischemia was affected by the COVID-19 pandemic, since there was a reduction in admissions for cardiovascular problems, increases in ischemia time, reduction of PCI and worse outcomes in patients with STEMI positive for COVID-19.
References
Abdelaziz H. K., Abdelrahmam A., Nabi A., Debski M., Mentias A., Choudhury T., Patel B. & Saad M. (2020). Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center. American Heart Journal, 226, 45-48.
Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari S., Shah B., Ibrahim H., Friedman G. H., Thompson C., Alviar C. L., Chadow H. L., Fishmann G., Reynolds H., Keller N. & Hochman J.S. (2020). ST-Segment Elevation in Patients with Covid-19 — A Case Series. N Engl J Med., 382 (25), 2478-2480.
Cinier G., Hayiroglu M., Pay L., Yumurtas A., Tezen O. & Parsova K. E. (2020). Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Turk Kardiyol Dern Ars., 48 (7), 640-645.
Calleja I. P., Velasco R. U., Lacayo M. A., Aguirre L. A., Fernandez P. A. & Tassa C. M. (2020). Impact of the COVID-19 pandemic on acute myocardial infarction care times. Emergencias, 32, 435-446.
Connolly N. P., Simpkin A., Mylotte D., Crowley J., Oconnor S., Alharbi K., Kiernan T., Arockiam S., Owens P., John A., Blake G. J., Fitzgerald S., Cagodan D. & Rosseel L. (2021). Impact on percutaneous coronary intervention for acute coronary syndromes during the COVID-19 outbreak in a non-overwhelmed European healthcare system: COVID-19 ACS-PCI experience in Ireland. BMJ Open, 11, 1-7.
Huet F., Prieur C., Schurtz G., Gerbaud E., Manzo-Silberman S., Vanzetto G., Elbaz M., Chá V., Mercier G., Lattuca B., Duflos C. & Roubille F. (2020). One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic. Archives of Cardiovascular Disease, 113 (05), 303-307.
Fernandes F. L. (2021). Preditores De recuperação em pacientes com choque cardiogênico secundário ao Infarto Agudo do Miocárdio tratados com oxigenação de membrana extracorpórea. Tese. Faculdade de medicina da Universidade de São Paulo.
Filippo O. D. (2020). Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med. 2020.
Ibanez B., James S., Agewall S., Antunes M. J., Buciarelli-Dulcci C., Bueno H., Caforio A. L. P, Crea F., Goudevenos J.A., Halvorsen S., Hindricks G., Kastrati A., Lenzen M. J., Prescott E., Roffi M., Valgimini M., Varenhorst C., Vranckx P. & Widimsky P. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 39 (02), 119-177.
Ishii H., Amano T., Yamaju K., Kohsaka S., Yokoi H. & Ikari Y. (2020). Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan - Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease. Circulation Journal Circ., 84 (12), 2185-2189.
Jun BU, Chen M, Cheng X, Dong Y, Fang W, Ge J, Gong Y, He B, Huang L., Huo Y., Jia S., Jiang J., Li Y., Li Z., Liang C., Liu X., Liu Z., Ma X., Ma Y., Qian J., Shen C., Shen D., Shen L., Shi R., Su X., Yingxian S., Tang Y., Wang J., Wu Y., Xiang D., Xu T., Xu Y., Yang Y., Zeng H., Zhang C., Zhang G., Zhang R., Zhang S., Zhang Y., Zhang Z., Zhang B. & Zhang N. (2020). Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition). Nan Fang Yi Ke Da Xue Xue Bao, 40 (2), 147–151.
Little C. D., Tushar K., Luciano C., Richard J., George C., Asrar A., Connoly M., Ritesh K., Ozan M., Lucy L.O., Brian W., Sam F., Sprat J.C., Perera D., MacCarthy P., Miles D., Ajain, J., Wilson S.J., Ikbal M. & Roby R (2020). COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group. Open Heart., 07 (02), 1-10.
Lu Q., Wang J. L., Chen Z. N., Fu W.B., Liu H. J. & Ding S. F. (2021). The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China. Reviews in Cardiovascular Medicine, 22 (01), 247-256.
Mafham M. M., Spata E., Goldacre R., Gair D., Curnow P., Bray M., Hollings S., Roebuck C., Gales C. P., Mamas M., Deanfield J., Belder M., Luescher T., Denwood B., Landray M. J., Emberson J., Coolins R., Morrias E., Casadei B. & Baigent C. (2020). COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet, 396 (10248), 381–389.
Melnyk B. M. & Fineout-Overholt E. (2011). Evidence-based practice in nursing & healthcare: a guide to best practice. Lippincott.
Mendes K. D. S., Silveira R.C.C.P. & Galvão C.M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm., 17 (4),758-764.
Nan J., Mheg S., Hu H., Jia R., Chen W., Li Q., Zhang T., Ke C., Wang Y. & Jin Z (2020). Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020. Med Sci Monit., 26, 1-7.
Normando P. G., Araújo-Filho J. A., Fonseca G. A., Rodrigues R. E. F., Oliveira V. A., Hajjar L. A., Almeida A. L. C., Bocchi E. A., Salemi V. M. C. & Melo M. (2021). Redução na hospitalização e aumento da mortalidade por doenças cardiovasculares durante a pandemia da COVID-19 no Brasil. Arquivos Brasileiros de Cardiologia, 116 (03), 371-380.
Oliveira J. C., Barros M. P. S., Barreto I.D.C., Filho R.C.S., Andrade V. A., Oliveira A. M., Lima T. C. R. M., Oliveira J. C., Arcelino L. A. M., Oliveira L. C. S., Santos E. S., Santoas M. A. S., Sousa A. C., Filho J. A. S. B (2021). Access to Reperfusion Therapy and Mortality in Women with ST-Segment–Elevation Myocardial Infarction: VICTIM Register. Arq Bras Cardiol, 116 (4), 695-703.
Robles M .C., Corches C. L., Bradford M., Tia A., Sukul D., Springer M. V., Bailey S., Oliver A. & Skolarus L. (2021). Understanding and Informing Community Emergency Cardiovascular Disease Preparedness during the COVID-19 Pandemic: Stroke Ready. Journal of Stroke and Cerebrovascular Diseases, 30 (2), 1-15.
Santos E. B. & Bianco H. T. (2018). Atualizações em doença cardíaca isquêmica aguda e crônica. Rev Soc Bras Clin Med., 16 (1), 52-58.
Seiffert M., Brunner F. J., Remmel M., Thomalla G., Marschall U., L’Hoest H., Acar L., Debus E. S., Blankenberg S., Gerlof C. & Behrendt C. (2020). Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims. Clin Res Cardiol, 109, 1540–1548.
Sociedade Brasileira de Cardiologia (2015). V Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do Miocárdio com Supradesnível do Segmento. Revista da Sociedade Brasileira de Cardiologia, 105 (2).
Schwarz V., Mahfoud F., Lauder L., Reither W., Behnke S., Smola S., Rissland J., Pfuhl T., Scheller B., Bohm M. & Ewen S. (2020). Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19. Clin Res Cardiol, 109, 1500–1506.
Scholz K. H., Lengenfelder B., Thilo C., Jeron A., Stefanow S., Jansseens U., Bauersachs J., Schulze P .C., Winter, K. D., Schroder J., Dahl J. V., Beckerath N. V., Seidl K. & Friede T. (2020). Impact of COVID-19 outbreak on regional STEMI care in Germany. Clin Res Cardiol., 109, 1511–1521.
Tam C. C. F., Cheung K. S., Lam S., Wong A., Yung A., Sze M. (2020). Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes, 13 (04), 01-07.
Zhang L., Yongzhen F. & Lu Z. (2020). Compromised STEMI reperfusion strategy in the era of COVID-19 pandemic: pros and cons.European Heart Journal, 41 (42), 119-177.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Fernanda Gomes de Magalhães Soares Pinheiro; Debora Santana Santos; Ingrid Melo Santos; Laura Dayane Gois Bispo; Natan Martins Machado; Eduesley Santana Santos; Jussiely Cunha Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
